Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cristea

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|October 29, 2014
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumorsM Koczywas, P H Frankel, T W Synold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian CancerAlexi A Wright, Angel Cronin, Dana E Milne, et al.
Clinical Lung Cancer|March 22, 2021
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811)Athanassios Argiris, Jieling Miao, Mihaela C Cristea, et al.
Nature Communications|May 25, 2021
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancerAritro Nath, Patrick A Cosgrove, Hoda Mirsafian, et al.
Cancer|April 15, 2021
Germline mutations and age at onset of lung adenocarcinomaKaren L Reckamp, Carolyn E Behrendt, Thomas P Slavin, et al.
Annals of Surgical Oncology|September 14, 2023
Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian CancerRosemary N Senguttuvan, Nicole Lugo Santiago, Ernest S Han, et al.
Gynecologic Oncology|May 17, 2024
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparibJoyce F Liu, Niya Xiong, Robert M Wenham, et al.
Cancer Chemotherapy and Pharmacology|April 22, 2020
Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumorsGeraldine O 'Sullivan Coyne, Lihua Wang, Jennifer Zlott, et al.
JAMA Oncology|November 18, 2017
Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical CarcinomaStephanie Lheureux, Marcus O Butler, Blaise Clarke, et al.
JCO Precision Oncology|March 31, 2022
Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian CancerThanh H Dellinger, Ernest S Han, Mustafa Raoof, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|October 29, 2014
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumorsM Koczywas, P H Frankel, T W Synold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian CancerAlexi A Wright, Angel Cronin, Dana E Milne, et al.
Clinical Lung Cancer|March 22, 2021
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811)Athanassios Argiris, Jieling Miao, Mihaela C Cristea, et al.
Nature Communications|May 25, 2021
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancerAritro Nath, Patrick A Cosgrove, Hoda Mirsafian, et al.
Cancer|April 15, 2021
Germline mutations and age at onset of lung adenocarcinomaKaren L Reckamp, Carolyn E Behrendt, Thomas P Slavin, et al.
Annals of Surgical Oncology|September 14, 2023
Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian CancerRosemary N Senguttuvan, Nicole Lugo Santiago, Ernest S Han, et al.
Gynecologic Oncology|May 17, 2024
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparibJoyce F Liu, Niya Xiong, Robert M Wenham, et al.
Cancer Chemotherapy and Pharmacology|April 22, 2020
Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumorsGeraldine O 'Sullivan Coyne, Lihua Wang, Jennifer Zlott, et al.
JAMA Oncology|November 18, 2017
Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical CarcinomaStephanie Lheureux, Marcus O Butler, Blaise Clarke, et al.
JCO Precision Oncology|March 31, 2022
Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian CancerThanh H Dellinger, Ernest S Han, Mustafa Raoof, et al.
Pageof 6